Currencies / BNTX
BNTX: BioNTech SE - American Depositary Shares
102.02
USD
16.71
(14.07%)
BNTX exchange rate has changed by -14.07% for today. During the day, the instrument was traded at a low of 93.17 and at a high of 118.73.
Follow BioNTech SE - American Depositary Shares dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BNTX News
- Investing Novavax shares fall following WSJ report on FDA trial request
- Investing As FDA delays Novavax’ COVID vaccine approval, patients fight back
- Benzinga Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps - Novavax (NASDAQ:NVAX)
- Investor's Business Daily BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
- Benzinga Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday - Amer Sports (NYSE:AS), Amphenol (NYSE:APH)
- Seeking Alpha IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA)
- Benzinga Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study - Novavax (NASDAQ:NVAX)
- Investing China’s Duality Biotherapeutics surges over 200% in Hong Kong trading debut
- Seeking Alpha Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition (SMMT)
- Seeking Alpha Novavax: Regulatory Uncertainty Creates Risk And Opportunity
- Seeking Alpha FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (MRNA)
- Seeking Alpha CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions (NASDAQ:CVAC)
- Benzinga European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - CureVac (NASDAQ:CVAC)
- Investing Lululemon, General Motors and Apple fall premarket; CureVac gains
- Investing Citi says SMid biotechs alternative to large caps as it starts coverage
- The Motley Fool BioNTech Se (BNTX) Q4 2024 Earnings Call Transcript
- Benzinga Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? - SPDR S&P 500 (ARCA:SPY)
- Seeking Alpha BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript
- Benzinga Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations - BioNTech (NASDAQ:BNTX)
- Seeking Alpha BioNTech SE 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:BNTX)
- The Motley Fool BioNTech Surpasses Q4 Revenue Estimates
- Benzinga US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory - Mission Produce (NASDAQ:AVO), American Public Education (NASDAQ:APEI)
- Benzinga Dow Gains Over 200 Points But Records Weekly Loss: Fear Among Investors Eases But Greed Index Remains In 'Extreme Fear' Zone - American Public Education (NASDAQ:APEI), BioNTech (NASDAQ:BNTX)
- Benzinga BioNTech, Oracle And 3 Stocks To Watch Heading Into Monday - Mission Produce (NASDAQ:AVO), BioNTech (NASDAQ:BNTX)
Daily Range
93.17
118.73
Year Range
76.53
131.49
- Previous Close
- 120.54
- Open
- 118.73
- Bid
- 102.02
- Ask
- 102.32
- Low
- 93.17
- High
- 118.73
- Volume
- 17.330 K
- Daily Change
- -14.07%
- Month Change
- 10.98%
- 6 Months Change
- -8.81%
- Year Change
- 17.58%
26 April, Saturday
00:00
ALL
- Act
- Fcst
- Prev